Graeme Purdy, CEO of Ilika plc, outlines how solid-state Stereax batteries are entering production at Cirtec—with customer-ready units already on test. Applications span implanted sensors to orthodontics, and next-gen Goliath cells are primed for delivery by year-end...
Meren Energy’s Shahin Amini reveals how the company delivered $100M in dividends, halved debt, and secured funding for the Venus field — all while positioning for high-impact drilling in Nigeria and Namibia..
EMX, have always believed that a diverse portfolio of mineral rights and royalties offers shareholders a powerful way to access both commodity price upside and exploration-driven growth...
Record’s EMSF strategy combines emerging market currencies with DFI bonds, achieving strong returns while supporting local currency funding and development goals across frontier economies...
Record plc CEO Dr Jan Hendrik Witte outlines how the firm’s transition from FX-focused services into private market strategies is positioning it for scale and long-term growth...
Cizzle Biotechnology has signed a letter of intent with an NHS-linked diagnostics partner to begin UK validation of its CIZ1B lung cancer test. Executive Chairman Dr Allan Syms outlines how this complements their existing US licence and supports national early detection targets...
Quintessentially Group, the global luxury lifestyle and concierge group, has partnered with the Abu Dhabi Investment Office (ADIO) to launch a bespoke concierge service for Ultra High-Net-Worth Individuals in Abu Dhabi..
One Health Group’s Chairman Derek Bickerstaff outlines another period of strong growth — with patient referrals, surgeons, and capacity all sharply higher...
Verge Technologies’ Jimmy Jobe reveals how AI-powered, self-healing database systems are eliminating the fragility of single-cloud dependence. With SentientDB at its core, Verge is building a future where enterprise data never goes dark...
RECI offers something rare: liquid access to a booming but illiquid market. Harman & Co’s Mark Thomas explains how this unique real estate credit investor continues to provide strong returns through macro turbulence—with a model that hasn’t flinched in six years...
AW1 is more than just a battery project. David Taaffe explains how Ampeak Energy’s flagship development has triggered a domino effect across its multi-GWh pipeline — paving the way for £100 million in future annual revenues...
Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
Graeme Purdy, CEO of Ilika plc, outlines how solid-state Stereax batteries are entering production at Cirtec—with customer-ready units already on test. Applications span implanted sensors to orthodontics, and next-gen Goliath cells are primed for delivery by year-end...
Meren Energy’s Shahin Amini reveals how the company delivered $100M in dividends, halved debt, and secured funding for the Venus field — all while positioning for high-impact drilling in Nigeria and Namibia..
EMX, have always believed that a diverse portfolio of mineral rights and royalties offers shareholders a powerful way to access both commodity price upside and exploration-driven growth...
Record’s EMSF strategy combines emerging market currencies with DFI bonds, achieving strong returns while supporting local currency funding and development goals across frontier economies...
Record plc CEO Dr Jan Hendrik Witte outlines how the firm’s transition from FX-focused services into private market strategies is positioning it for scale and long-term growth...
Cizzle Biotechnology has signed a letter of intent with an NHS-linked diagnostics partner to begin UK validation of its CIZ1B lung cancer test. Executive Chairman Dr Allan Syms outlines how this complements their existing US licence and supports national early detection targets...
Quintessentially Group, the global luxury lifestyle and concierge group, has partnered with the Abu Dhabi Investment Office (ADIO) to launch a bespoke concierge service for Ultra High-Net-Worth Individuals in Abu Dhabi..
One Health Group’s Chairman Derek Bickerstaff outlines another period of strong growth — with patient referrals, surgeons, and capacity all sharply higher...
Verge Technologies’ Jimmy Jobe reveals how AI-powered, self-healing database systems are eliminating the fragility of single-cloud dependence. With SentientDB at its core, Verge is building a future where enterprise data never goes dark...
RECI offers something rare: liquid access to a booming but illiquid market. Harman & Co’s Mark Thomas explains how this unique real estate credit investor continues to provide strong returns through macro turbulence—with a model that hasn’t flinched in six years...
AW1 is more than just a battery project. David Taaffe explains how Ampeak Energy’s flagship development has triggered a domino effect across its multi-GWh pipeline — paving the way for £100 million in future annual revenues...
Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
